Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.180
0.00 (0.00%)
Sep 30, 2026, 9:52 AM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.4 billion as of October 1, 2026. Its market cap has decreased by -5.30% in one year.
Market Cap
2.40B
Enterprise Value
3.23B
Revenue
2.18B
Ranking
n/a
PE Ratio
28.93
Stock Price
1.18
ChartMarket Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.40B, a decrease of -64.31%. That is a compound annual growth rate of -13.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.40B | 18.37% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.05B |
| BioDlink International Company | 2.95B |
| Jiangsu Recbio Technology | 2.72B |
| Beijing Luzhu Biotechnology | 2.67B |
| HJ Science | 2.66B |
| Clover Biopharmaceuticals | 2.40B |
| Antengene Corporation | 2.38B |
| AIM Vaccine | 2.09B |